Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 1;20(1):348.
doi: 10.1186/s12951-022-01550-2.

Long-term maintenance of synaptic plasticity by Fullerenol Ameliorates lead-induced-impaired learning and memory in vivo

Affiliations

Long-term maintenance of synaptic plasticity by Fullerenol Ameliorates lead-induced-impaired learning and memory in vivo

Yingying Zha et al. J Nanobiotechnology. .

Abstract

Fullerenol, a functional and water-soluble fullerene derivative, plays an important role in antioxidant, antitumor and antivirus, implying its enormous potential in biomedical applications. However, the in vivo performance of fullerenol remains largely unclear. We aimed to investigate the effect of fullerenol (i.p., 5 mg/kg) on the impaired hippocampus in a rat model of lead exposure. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) is a kind of newly developed soft-ionization mass spectrometry technology. In the present study, an innovative strategy for biological distribution analysis using MALDI-TOF-MS confirmed that fullerenol could across the blood-brain barrier and accumulate in the brain. Results from behavioral tests showed that a low dose of fullerenol could improve the impaired learning and memory induced by lead. Furthermore, electrophysiology examinations indicated that this potential repair effect of fullerenol was mainly due to the long-term changes in hippocampal synaptic plasticity, with enhancement lasting for more than 2-3 h. In addition, morphological observations and biochemistry analyses manifested that the long-term change in synaptic efficacy was accompanied by some structural alteration in synaptic connection. Our study demonstrates the therapeutic feature of fullerenol will be beneficial to the discovery and development as a new drug and lays a solid foundation for further biomedical applications of nanomedicines.

Keywords: Fullerenol; In vivo; Lead-induced impairment; Learning and memory; Synaptic plasticity.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Schematics of the experimental procedures and characterization of fullerenol. A Experimental timeline, B Transmission electron microscope image, C Size distribution and zeta potential of fullerenol (1 μM, dissolved in water)
Fig. 2
Fig. 2
Fullerenol may across the blood–brain barrier and lead can accumulate in the body. A Mass spectrometry of water-suspended fullerenol, B–E Distribution of exogenous fullerenol in brain, Liver, Kidney and spleen were detected by MALDI-TOF–MS. F Lead contents in blood and hippocampus of experiment rats were analyzed by ICP-MS. MALDI-TOF–MS: Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight Mass Spectrometry; ICP-MS: Inductively Coupled Plasma Mass Spectrometry. One-way ANOVA analysis with Tukey-test post hoc analysis. *** p < 0.001 compared with the control group
Fig. 3
Fig. 3
Fullerenol improved hippocampus-dependent spatial learning and memory. A, B The number of crossing squares and rearing in open field test indicated that exploratory activity of rats were normal. C–F The performances of rats in Morris water maze, including latency to the correct platform during training period, time-spent in the correct area, latency to the correct area and velocity, indicated that fullerenol improved the learning and memory. Two-way ANOVA with Tukey-test post hoc analysis was used in the training period of the Morris Water Maze. One-way ANOVA with Tukey-test post hoc analysis was for all other studies. ** p < 0.01, *** p < 0.001 compared with the control group. ## p < 0.01, ### p < 0.001 compared with the lead-exposed group. N.S. not significant
Fig. 4
Fig. 4
Fullerenol enhanced long-term synaptic plasticity in hippocampal PP-DG pathway. A, B The I/O curve shown as fEPSP slope and PS amplitude, CD The PPF ratio shown as fEPSP2/fEPSP1 and PS2/PS1, EF The LTP induction shown as fEPSP slope in percent and PS amplitude in percent indicated that long-term maintenance of synaptic plasticity by fullerenol was found in hippocampal DG area. One-way ANOVA with Tukey-test post hoc analysis was used in the peak analysis of the PPF ratio curve. Two-way ANOVA with Tukey-test post hoc analysis was for all other studies. * p < 0.05, ** p < 0.01, *** p < 0.001 compared with the control group. # p < 0.05, ### p < 0.001 compared with the lead-exposed group
Fig. 5
Fig. 5
Fullerenol enhanced long-term synaptic plasticity in hippocampal Sch-CA1 pathway. A The I/O curve shown as fEPSP slope, B The PPF ratio shown as fEPSP2/fEPSP1, The LTP induction shown as fEPSP slope in percent indicated that long-term maintenance of synaptic plasticity by fullerenol was found in hippocampal CA1 area. One-way ANOVA with Tukey-test post hoc analysis was used in the peak analysis of the PPF ratio curve. Two-way ANOVA with Tukey-test post hoc analysis was for all other studies. ** P < 0.01, *** P < 0.001 compared with the control group. ## P < 0.01, ### P < 0.001 compared with the lead-exposed group
Fig. 6
Fig. 6
The PSD-dependent structural alteration by fullerenol at the synapse in hippocampus. A, B Representative image and statistical analysis of the number of spines, C, D The number of PSD, E, F Western blot and statistical analysis of PSD95 protein, p-CaMKIIα/total CaMKII showed that fullerenol up-regulated the PSD-dependent structures. One-way ANOVA with Tukey-test post hoc analysis. The estimation of mixed effect model used in statistical analysis of the number of spines eliminated the type I error from the random effect. Date were represented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001 compared with the control group. # p < 0.05, ### p < 0.001 compared with the lead-exposed group
Fig. 7
Fig. 7
The protective effect of fullerenol was not dependent on the reduction–oxidation pathway. A The H2O2 level. B The total SOD activity. C The total antioxidant capacity. D The total GSH concentration. One-way ANOVA with Tukey-test post hoc analysis. * p < 0.05, ** p < 0.01, *** p < 0.001 compared with the control group

Similar articles

Cited by

References

    1. Prylutskyy YI, Petrenko VI, Ivankov OI, Kyzyma OA, Bulavin LA, Litsis OO, et al. On the origin of C(6)(0) fullerene solubility in aqueous solution. Langmuir. 2014;30(14):3967–3970. doi: 10.1021/la404976k. - DOI - PubMed
    1. Malhotra N, Audira G, Castillo AL, Siregar P, Ruallo JMS, Roldan MJ, et al. An update report on the biosafety and potential toxicity of fullerene-based nanomaterials toward aquatic animals. Oxid Med Cell Longev. 2021;2021:7995223. doi: 10.1155/2021/7995223. - DOI - PMC - PubMed
    1. Sharoyko VV, Shemchuk OS, Meshcheriakov AA, Vasina LV, Iamalova NR, Luttsev MD, et al. Biocompatibility, antioxidant activity and collagen photoprotection properties of C60 fullerene adduct with L-methionine. Nanomedicine. 2021;40:102500. doi: 10.1016/j.nano.2021.102500. - DOI - PubMed
    1. Krizova I, Dostalkova A, Castro E, Prchal J, Hadravova R, Kaufman F, et al. Fullerene derivatives prevent packaging of viral genomic RNA into HIV-1 particles by binding nucleocapsid protein. Viruses. 2021;13(12):2451. doi: 10.3390/v13122451. - DOI - PMC - PubMed
    1. Cao H, Zhang L, Qu Z, Tian S, Wang Z, Jiang Y, et al. The protective effect of hydroxylated fullerene pretreatment on pilocarpine-induced status epilepticus. BRAIN RES. 2021;1764:147468. doi: 10.1016/j.brainres.2021.147468. - DOI - PubMed

LinkOut - more resources